You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Analysis Tools for Detection and Diagnosis of Biological Threats
SBC: ALPHA-GAMMA TECHNOLOGIES, INC. Topic: CBD04113DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this proposal is to demonstrate the feasibility of building a data management system for DN ...
SBIR Phase I 2004 Department of DefenseOffice for Chemical and Biological Defense -
A Next Generation, High-Precision, Field Drug Detection System
SBC: SensoDX II, LLC Topic: A16AT008The synthetic opioids fentanyl and carfentanil pose an imminent national security threat, given the ease with which they can be obtained, their low lethal doses, and their potential for weaponized use. The purpose of this agreement is to adapt SensoDx’s high-performance miniaturized diagnostics platform based on a programmable bio-nano-chip, with embedded artificial intelligence, to enable U.S. ...
SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense -
Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment
SBC: ZYMERON CORPORATION Topic: CBD181004Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Hermetic Textile Closure Hardware System
SBC: SIGMA K CORP Topic: CBD04110Sigma-K Corporation proposes to develop a Hermetic Textile Closure Hardware System to be used for Chemical Biological (CB) protective clothing and Collective Protection (COLPRO) portable shelter systems. Our Hermetic Textile Closure Hardware System design will allow the user to easily don and doff one's protective apparel. The system will remain intact during combat behavior. The closure interface ...
SBIR Phase I 2004 Department of DefenseOffice for Chemical and Biological Defense -
Narrowband Perfect Absorber using Metamaterials
SBC: PHOEBUS OPTOELECTRONICS LLC Topic: CBD11102We will continue developing a plasmonic metamaterial with strong absorption within a narrow band that is dynamically tunable over the 8-10 micron range. A metamaterial consisting of one or more bi-layers of thin metal and dielectric films will trap, concentrate and absorb a narrow frequency band while strongly reflecting out-of-band light. Tuning the frequency of the absorption band may be achiev ...
SBIR Phase II 2013 Department of DefenseOffice for Chemical and Biological Defense -
Sensitive Molecular Beacons (MB) Based DNA Microarray
SBC: BIOMACHINES, INC. Topic: CBD02101In the wake of the September 11th attacks and subsequent Anthrax scares, researchers worldwide are working to expand our ability to rapidly assess what poses a terrorism threat to the public. The rapid detection of specific pathogens is required for biod
SBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense